LOS ANGELES, June 6, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Goldman Sachs 34th Annual Global Healthcare Conference in Palos Verdes, CA.
|Event: Goldman Sachs 34th Annual Global Healthcare Conference in Palos Verdes, CA|
|Date: Thursday, June 13, 2013|
|Time: 8:00 a.m. PDT|
A live webcast will be available under the Investors section of the Company's website at www.kytherabiopharma.com. The presentation will be archived on the website and will be available for at least 14 days.
About KYTHERA Biopharmaceuticals, Inc.
KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA's product candidate, ATX-101, is a potential first-in-class, injectable treatment currently in Phase III clinical development for the reduction of submental fat, which commonly presents as an undesirable "double chin." KYTHERA also maintains an active research interest in hair and fat biology, pigmentation modulation and facial contouring. Find more information at http://www.kytherabiopharma.com.
CONTACT: Heather Rowe Associate Director, Investor Relations Tel: (818) 587-4559 firstname.lastname@example.org
Source:KYTHERA Biopharmaceuticals, Inc.